Loss and functional gain assays showed that LINC01303 affects GC cell proliferation, migration and invasion by acting as a miR‐101‐3p ceRNA, thereby preventing miR‐101‐3p from binding to the target protein EZH2. Here, EZH2 is linked to gastric cancer.